Gail F Schwartz, Gregory Reardon. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh： See more » AmidesAntihypertensive Agents/economicsBimatoprostCloprostenol/analogs & derivativesCost-Benefit AnalysisDrug CostsEconomics, PharmaceuticalGlaucoma, Open-Angle/drug therapyGlaucoma, Open-Angle/economicsHumansIntraocular Pressure/drug effectsLatanoprostLipids/economicsModels, EconomicOcular Hypertension/drug therapyOcular Hypertension/economicsProstaglandins F, Synthetic/economics
Substances： See more » AmidesAntihypertensive AgentsLipidsProstaglandins F, SyntheticCloprostenolLatanoprostBimatoprost
Year: 2004 PMID： 15530957 DOI： 10.1016/j.survophthal.2004.08.017
Source DB: PubMed Journal: Surv Ophthalmol ISSN： 0039-6257 Impact factor: 6.048